Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cell-Penetrating, Guanidinium-Rich Oligophosphoesters: Effective and Versatile Molecular Transporters for Drug and Probe Delivery.

McKinlay CJ, Waymouth RM, Wender PA.

J Am Chem Soc. 2016 Mar 16;138(10):3510-7. doi: 10.1021/jacs.5b13452. Epub 2016 Mar 7.

2.

Guanidinium-rich, glycerol-derived oligocarbonates: a new class of cell-penetrating molecular transporters that complex, deliver, and release siRNA.

Wender PA, Huttner MA, Staveness D, Vargas JR, Xu AF.

Mol Pharm. 2015 Mar 2;12(3):742-50. doi: 10.1021/mp500581r. Epub 2015 Jan 27.

3.

Stepwise orthogonal click chemistry toward fabrication of paclitaxel/galactose functionalized fluorescent nanoparticles for HepG2 cell targeting and delivery.

Lai CH, Chang TC, Chuang YJ, Tzou DL, Lin CC.

Bioconjug Chem. 2013 Oct 16;24(10):1698-709. doi: 10.1021/bc400219t. Epub 2013 Sep 19.

PMID:
23987828
4.

Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.

Koo H, Min KH, Lee SC, Park JH, Park K, Jeong SY, Choi K, Kwon IC, Kim K.

J Control Release. 2013 Dec 28;172(3):823-31. doi: 10.1016/j.jconrel.2013.08.297. Epub 2013 Sep 11.

PMID:
24035978
5.

Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery.

Yamada R, Kostova MB, Anchoori RK, Xu S, Neamati N, Khan SR.

Cancer Biol Ther. 2010 Feb;9(3):192-203. Epub 2010 Feb 16.

PMID:
20023432
6.

Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.

Zhang R, Luo K, Yang J, Sima M, Sun Y, Janát-Amsbury MM, Kopeček J.

J Control Release. 2013 Feb 28;166(1):66-74. doi: 10.1016/j.jconrel.2012.12.009. Epub 2012 Dec 20.

7.

Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance.

Vargas JR, Stanzl EG, Teng NN, Wender PA.

Mol Pharm. 2014 Aug 4;11(8):2553-65. doi: 10.1021/mp500161z. Epub 2014 May 9. Review.

8.

Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.

Saravanakumar G, Min KH, Min DS, Kim AY, Lee CM, Cho YW, Lee SC, Kim K, Jeong SY, Park K, Park JH, Kwon IC.

J Control Release. 2009 Dec 16;140(3):210-7. doi: 10.1016/j.jconrel.2009.06.015. Epub 2009 Jun 26.

PMID:
19560497
9.

pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.

Dalela M, Shrivastav TG, Kharbanda S, Singh H.

ACS Appl Mater Interfaces. 2015 Dec 9;7(48):26530-48. doi: 10.1021/acsami.5b07764. Epub 2015 Nov 23.

PMID:
26528585
10.

Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.

Li J, Huo M, Wang J, Zhou J, Mohammad JM, Zhang Y, Zhu Q, Waddad AY, Zhang Q.

Biomaterials. 2012 Mar;33(7):2310-20. doi: 10.1016/j.biomaterials.2011.11.022. Epub 2011 Dec 12.

PMID:
22166223
11.

"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.

Xiao K, Li Y, Lee JS, Gonik AM, Dong T, Fung G, Sanchez E, Xing L, Cheng HR, Luo J, Lam KS.

Cancer Res. 2012 Apr 15;72(8):2100-10. doi: 10.1158/0008-5472.CAN-11-3883. Epub 2012 Mar 6.

12.

Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.

Yin T, Wu Q, Wang L, Yin L, Zhou J, Huo M.

Mol Pharm. 2015 Aug 3;12(8):3020-31. doi: 10.1021/acs.molpharmaceut.5b00280. Epub 2015 Jun 30.

PMID:
26086430
13.

PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.

Zhang X, Lu J, Huang Y, Zhao W, Chen Y, Li J, Gao X, Venkataramanan R, Sun M, Stolz DB, Zhang L, Li S.

Bioconjug Chem. 2013 Mar 20;24(3):464-72. doi: 10.1021/bc300608h. Epub 2013 Mar 1.

14.

Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.

Wang X, Deng L, Chen X, Pei H, Cai L, Zhao X, Wei Y, Chen L.

J Pharm Sci. 2011 Mar;100(3):1196-205. doi: 10.1002/jps.22348. Epub 2010 Sep 21.

PMID:
20860011
15.

Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery.

Wender PA, Rothbard JB, Jessop TC, Kreider EL, Wylie BL.

J Am Chem Soc. 2002 Nov 13;124(45):13382-3.

PMID:
12418880
16.

Oligocarbonate molecular transporters: oligomerization-based syntheses and cell-penetrating studies.

Cooley CB, Trantow BM, Nederberg F, Kiesewetter MK, Hedrick JL, Waymouth RM, Wender PA.

J Am Chem Soc. 2009 Nov 18;131(45):16401-3. doi: 10.1021/ja907363k.

17.

Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.

Pandey V, Gajbhiye KR, Soni V.

Drug Deliv. 2015 Feb;22(2):199-205. doi: 10.3109/10717544.2013.877100. Epub 2014 Jan 27.

PMID:
24467582
18.

Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth.

Sharma S, Verma A, Pandey G, Mittapelly N, Mishra PR.

Acta Biomater. 2015 Oct;26:169-83. doi: 10.1016/j.actbio.2015.08.005. Epub 2015 Aug 8.

PMID:
26265061
19.

PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.

Chu B, Qu Y, Huang Y, Zhang L, Chen X, Long C, He Y, Ou C, Qian Z.

Int J Pharm. 2016 Mar 16;500(1-2):345-59. doi: 10.1016/j.ijpharm.2016.01.030. Epub 2016 Jan 18.

PMID:
26794876
20.

Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.

Eldar-Boock A, Miller K, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R.

Biomaterials. 2011 May;32(15):3862-74. doi: 10.1016/j.biomaterials.2011.01.073. Epub 2011 Mar 4.

Supplemental Content

Support Center